Prosecution Insights
Last updated: November 04, 2026
Application No. 18/896,929

EMULSIFYING WAX FOR SOLID COSMETIC COMPOSITIONS

Non-Final OA §103
Filed
Sep 26, 2024
Priority
Sep 29, 2023 — IT 102023000020115
Examiner
BASQUILL, SEAN M
Art Unit
1614
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Brasca Industrial Srl
OA Round
1 (Non-Final)
39%
Grant Probability
At Risk
1-2
OA Rounds
1y 3m
Est. Remaining
60%
With Interview

Examiner Intelligence

Grants only 39% of cases
39%
Career Allowance Rate
416 granted / 1074 resolved
-21.3% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
46 currently pending
Career history
1135
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
54.3%
+14.3% vs TC avg
§102
8.0%
-32.0% vs TC avg
§112
19.4%
-20.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1074 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of the wax composition of Claim 1 in the reply filed on 17 August 2026 is acknowledged. The traversal is on the grounds that 1) because claim 5 is directed to a composition and not a method, it should be grouped with Claim 1; that Groups I and II are not mutually exclusive owing to the fact that there is no evidence supporting the use of the wax composition as a car polish, that the limitations of Invention II require the limitations of Invention I for patentability, and that therefore the Examiner has failed to meet their burden of establishing independence and distinctness; and 3) no serious search burden has been established. This is not found persuasive because while during examination claims are given their broadest reasonable interpretation consistent with the specification, Phillips v. AWH Corp., 415 F.3d 1303, 1316, 75 USPQ2d 1321, 1329 (Fed. Cir. 2005), and determination of patentability of a product-by-process claim is based on the product itself, rather than its method of production, In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985), structure implied by the process steps should be considered when assessing the patentability of product-by-process claims over the prior art, especially where the product can only be defined by the process steps by which the product is made, or where the manufacturing process steps would be expected to impart distinctive structural characteristics to the final product. In re Garnero, 412 F.2d 276, 279, 162 USPQ 221, 223 (CCPA 1979). Where, as here, the method of manufacture claimed may result in such structural differences, restriction placing the composition obtained by the process with the process claims itself is proper. Applicants arguments concerning the absence of evidence supporting the Examiner’s claim misstates the standard required for insisting on restriction, which is only that the particular reasons relied on by the examiner should be concisely stated: evidence is not required. See MPEP 808.01. Applicants are also reminded that Claim 1, and by extension Invention I, encompasses a composition which “consists of” and therefore contains only two components in particular ratios, while Claim 6 and by extension Invention III represents a composition “comprising” the wax and polyricinoleate of Claim 1. Applicants are no doubt aware that in the cosmetic arts, individual components are known to provide a multiplicity of benefits to compositions into which they have been incorporated. To be sure, waxes and polyricinoleates may serve as components of emulsifiers or “structuring agents” altering the viscosity or stability of compositions as applicants claims recite; However, cosmetic components such as emulsifiers or waxes including sunflower wax are also known to act as pearlescent components or emollients in such cosmetic compositions. This means that the language of Claim 6 specifying that no additional “emulsifier and/or structuring agent” be present does not foreclose the inclusion of additional components which may possess these properties, but which have been included for alternative reasons. The requirement is still deemed proper and is therefore made FINAL. Status of the Claims Claims 1-13 are pending. Claims 2-13 are withdrawn from examination as directed to non-elected inventions. Claim 1 is presented for examination and rejected as set forth below. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55 pertaining to Italian national application 102023000020115 filed 29 September 2023. Claim Interpretation Applicants Claim is directed to a composition consisting of sunflower seed wax obtained from Heliantuus annuus and either polyglyceryl-3-polyricinoleate or polyglyceryl-4-polyricinoleate, where the sunflower seed wax and polyricinoleate are present in a weight ratio of between 3-5:1. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Taylor (Mark Stewart Taylor, Stabilization of Water-in-Oil Emulsions to Improve the Emollient Properties of Lipstick, Masters Dissertation, School of Engineering The University of Birmingham (2011)), in view of Becker (Lillian C. Becker, et al, Safety Assessment of Helianthus annuus (Sunflower)-Derived Ingredients as Used in Cosmetics, 42 Int’l. J Toxicol. 93S (30 March 2023)). Taylor explores the formulation of water-in-oil emulsion lipsticks to improve the delivery of each of moisture and hydrophilic active ingredients to the lips. (Pg.2). Taylor indicates that waxes are incorporated into lipstick formulations to provide, among others, gloss, hardness, stability, and mouldability to the compositions being formulated, and incorporate, without limitations, waxes of natural origin with relatively high melting points such as carnauba wax, beeswax, and candelilla waxes. (Pg.11). Taylor indicates that the stability afforded lipstick compositions by these waxes is not dependent on viscosity or density changes brought about by their incorporation, but rather are attributable to surface-active interactions these waxes impart, rather than bulk properties of the system. (Pg.26-27). Taylor initially explores the combination of emulsifier and wax to later yield stable W/O emulsions for the manufacture of lipsticks, indicating that producing these emulsions using a crystalline wax matrix invariably results in more stable emulsion systems owing to steric stabilization. (Pg.42). Taylor indicates that selecting emulsifiers with similar hydrocarbon chain length and type to that of the lipophilic components has been shown to provide emulsions with maximum stability, and that PGPR, or polyglycerol polyricinoleate, synonymous with the polyglyceryl-polyricinoleates of the instant claims, was selected owing to its similarity to the castor oil later added to the crystalline wax matrix. (Pg.42-43). The examiner notes that ricinoleic acid, the fatty acid found in polyglyceryl polyricinoleate, is a C18 monounsaturated fatty acid. Taylor utilizes emulsifiers in concentrations of about 1-4% of the overall composition. (Pg.53) Despite describing basic lipstick formulations employing about 1-4% emulsifiers such as the PGPR of the instant claims with high melting point naturally occurring waxes to provide stability and structure to lipsticks, Taylor does not describe using a sunflower seed wax as the structural component of the lipstick. This is cured by the teachings of Becker, which indicates that Helianthus annuus (sunflower) seed derived components have long been used in cosmetics. (Abs.). More specifically, Becker indicates that sunflower seed waxes are not only known to be useful as skin conditioning agents, (95S), but that the wax has a melting point in the range of 74-80°C and contains a mixture of esters of C16-24 fatty acids. (96S). Becker indicates that lipsticks containing 4% sunflower seed wax are not only known in the art, but demonstrate no signs of the potential for dermal irritation when applied to the lips. (104-05S). It would have been prima facie obvious to have combined sunflower seed wax with polyglyceryl polyricinoleate in a 4:1 ratio and used this combination as an emulsifying wax base for incorporation into various lipstick compositions. One having ordinary skill in the art would have been motivated to do so because Taylor indicates that combinations of emulsifiers such as the PGPR of the instant claims in concentrations of about 1-4% and high melting point naturally occurring waxes are known to serve as lipophilic structural bases for the formation of O/W lipstick compositions. The use of sunflower seed wax, as taught by Becker, amounts to little more than the selection of a high melting point lipstick wax component known to be useful as a wax base for lipstick formulations. See Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945)(indicating that Generally, it is prima facie obvious to select a known material for incorporation into a composition, based on its recognized suitability for its intended use). In addition, given the structural similarity between the fatty acid esters contained in sunflower seed wax and the fatty acid chains of polyglyceryl polyricinoleate, the skilled artisan would expect that such a combination would provide improved stability to the overall lipstick compositions into which they are included. This is because Taylor establishes that emulsifiers having structurally similar hydrocarbon chains to the lipophilic components with which they are combined have been shown to provide such improved stability. See In re Sernaker, 702 F.2d 989, 994-95 (Fed. Cir. 1983) (“The strongest rationale for combining references is a recognition, expressly or impliedly in the prior art or drawn from a convincing line of reasoning based on established scientific principles or legal precedent, that some advantage or expected beneficial result would have been produced by their combination.”). Because Becker indicates that lipstick compositions including sunflower seed wax generally contain 4% sunflower seed wax, combined with Taylor’s recommendation that lipstick compositions contain between 1-4% emulsifier, the 4:1 ratio of wax to polyricinoleate is rendered obvious. See In re Peterson, 315 F.3d 1325, 1329 (Fed. Cir. 2003) (“A prima facie case of obviousness typically exists when the ranges of a claimed composition overlap the ranges disclosed in the prior art.”). Conclusion No Claims are allowable. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEAN M BASQUILL whose telephone number is (571)270-5862. The examiner can normally be reached Monday through Thursday, 5:30 AM to 4 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ali Soroush can be reached at (571) 272-9925. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEAN M BASQUILL/Primary Examiner, Art Unit 1614
Read full office action

Prosecution Timeline

Sep 26, 2024
Application Filed
Oct 28, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779090
GEL MATERIAL FOR TREATING TENDON OR LIGAMENT
3y 9m to grant Granted Nov 03, 2026
Patent 12778899
OCULAR DRUG DELIVERY
3y 2m to grant Granted Nov 03, 2026
Patent 12766217
EMBOLIC MICROSPHERES
4y 10m to grant Granted Oct 20, 2026
Patent 12751906
TOOTH WHITENING FILM, PROCESS OF MANUFACTURING THEREOF AND A METHOD OF USING SUCH A FILM
4y 11m to grant Granted Oct 06, 2026
Patent 12728101
FIBROUS COMPOSITE MATERIAL
3y 7m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
39%
Grant Probability
60%
With Interview (+21.6%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1074 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month